hodgkin lymphoma

Showing 1 - 25 of 232

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Hodgkin Lymphoma Trial (CTX-8371)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • (no location specified)
Dec 4, 2023

Lymphoma, Non-Hodgkin, Hodgkin Lymphoma Trial in Worldwide (AZD3470)

Not yet recruiting
  • Lymphoma
  • +2 more
  • Miami, Florida
  • +10 more
Nov 13, 2023

Venetoclax Tablets Crushed and Dissolved Into a Solution

Not yet recruiting
  • Hematologic Malignancy
  • +18 more
  • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Nov 8, 2023

Advanced Classical Hodgkin's Lymphoma in Brazil Treated With

Not yet recruiting
  • Hodgkin Lymphoma
  • No Intervention
  • Salvador, Bahia, Brazil
  • +5 more
Oct 23, 2023

Hodgkin Lymphoma, Relapse, Refractory Trial in Chapel Hill (Chemotherapy, Cell infusion)

Not yet recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 13, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
  • +1 more
Sep 22, 2023

Hodgkin Lymphoma Trial in Cologne (Pembrolizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Cologne, Germany
    1st Department of Medicine, Cologne University Hospital
Sep 19, 2023

Social and Genetic Factors on Outcomes in Adolescent and Young

Not yet recruiting
  • Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • Biospecimen Collection
  • +2 more
  • (no location specified)
Aug 18, 2023

Hodgkin Lymphoma Trial in Italy (Tislelizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Alessandria, IT, Italy
  • +9 more
Aug 4, 2023

Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma Trial (AVM0703, Hydrocortisone, Proton pump inhibitor)

Available
  • Glioblastoma
  • +13 more
  • (no location specified)
Jul 26, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +11 more
  • Health Promotion and Education
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jul 24, 2023

Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Aurora (Inspiratory muscle strength training, Sham Inspiratory muscle strength

Not yet recruiting
  • Hodgkin Lymphoma
  • Non Hodgkin Lymphoma
  • Inspiratory muscle strength training
  • Sham Inspiratory muscle strength training
  • Aurora, Colorado
  • +1 more
Jun 30, 2023

Hodgkin Lymphoma Trial in Houston (Brentuximab vedotin, Doxorubicin Hydrochloride, Pembrolizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Brentuximab vedotin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 20, 2023

Breast Cancer, Hodgkin Lymphoma, Kidney Cancer Trial (Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH)

Not yet recruiting
  • Breast Cancer
  • +9 more
  • Assessment tool IA3-CP with SDoH
  • Assessment tool IA3-CP without SDoH
  • (no location specified)
May 22, 2023

Non Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Miami (LIFE-L Mediterranean Diet, LIFE-L Home-Based Exercise Program, Supportive

Not yet recruiting
  • Non Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • LIFE-L Mediterranean Diet
  • +2 more
  • Miami, Florida
    University of Miami
Apr 19, 2023

Cognitive Impairment in Young Patients With Cancer Prospectively

Recruiting
  • Chemotherapy-Related Cognitive Impairment
  • +9 more
    • Copenhagen, Denmark
      Rigshospitalet
    Apr 24, 2023

    Hodgkin Lymphoma Trial in Saint Petersburg (Prolgolimab, Combination with prolgolimab and bendamustine)

    Recruiting
    • Hodgkin Lymphoma
    • Saint Petersburg, Russian Federation
    • +1 more
    Mar 3, 2023

    Hodgkin Lymphoma Trial in Salt Lake City (Axatilimab, Nivolumab)

    Not yet recruiting
    • Hodgkin Lymphoma
    • Salt Lake City, Utah
      Huntsman Cancer Institute at the University of Utah
    Feb 1, 2023

    Non Hodgkin Lymphoma, Heart; Functional Disturbance, Hodgkin Lymphoma Trial in Winston-Salem, Richmond (other, diagnostic test,

    Recruiting
    • Non Hodgkin Lymphoma
    • +3 more
    • Exercise with Trainerize application
    • +5 more
    • Winston-Salem, North Carolina
    • +1 more
    Feb 2, 2023

    Cardiovascular Disease in Hodgkin Lymphoma Survivors

    Not yet recruiting
    • Hodgkin Lymphoma
    • +3 more
    • Patient Self Reporting
    • +2 more
    • (no location specified)
    Jan 20, 2023

    Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

    Recruiting
    • Non-Hodgkin Lymphoma
    • Hodgkin Lymphoma
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Jan 25, 2023

    Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

    Recruiting
    • Colorectal Cancer
    • +11 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 18, 2023

    Non Hodgkin Lymphoma, Hodgkin Lymphoma, Myeloma Trial in Tampa (CC-486, Duvelisib)

    Recruiting
    • Non Hodgkin Lymphoma
    • +3 more
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 18, 2023

    Ovarian Reserve in Younger Newly Diagnosed Lymphomas

    Active, not recruiting
    • Anaplastic Large Cell Lymphoma
    • +4 more
    • Laboratory Biomarker Analysis
    • Questionnaire Administration
    • Birmingham, Alabama
    • +106 more
    Jan 11, 2023

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +17 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center & Research Institute
    Jan 10, 2023